Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Wien Med Wochenschr ; 173(7-8): 192-197, 2023 May.
Artigo em Alemão | MEDLINE | ID: mdl-36040634

RESUMO

This article presents the case of a 15-year-old adolescent presenting with myocarditis 4 days after receiving the 2nd dose of BNT162b2 mRNA vaccine (Comirnaty®) with no other identifiable cause. The main clinical symptom at presentation was chest pain. We found an elevated level of Troponin­I with preserved left ventricular systolic function. The cardiac MRI showed a clear pathologic result. With symptomatic therapy and strict bed rest, the symptoms resolved quickly and revealed a mild course.


Assuntos
Vacina BNT162 , Miocardite , Adolescente , Humanos , Miocardite/induzido quimicamente , Miocardite/diagnóstico , Vacinas Sintéticas , Vacinas de mRNA
2.
BMC Public Health ; 20(1): 178, 2020 Feb 04.
Artigo em Inglês | MEDLINE | ID: mdl-32019542

RESUMO

BACKGROUND: In Austria paediatric influenza-associated hospitalisations and deaths have never been systematically monitored. We examined the influenza season 2017/18 in terms of hospitalisation and mortality in the Austrian paediatric population and put the results into perspective of the available data from the last 15 years. METHODS: Cases of influenza-associated hospitalisations and deaths for season 2017/18 in children below 18 years were retrospectively collected from 12 and 33 Austrian hospitals, respectively. Hospitalisation and mortality rates for the whole Austrian paediatric population were estimated, adjusting for the population in each catchment area. Two Austrian databases were queried for hospitalisations and deaths associated with influenza during 2002-2016. Rough estimate of the vaccination coverage was calculated from a survey on 100 inpatients. RESULTS: Influenza-related paediatric hospitalisation rate in season 2017/18 was estimated as 128 (CI: 122-135) per 100,000 children, much higher than the national average of 40 per 100,000 over the years 2002-2016. There were nine reported influenza-associated deaths among children, resulting in mortality rate of 0.67 (CI: 0.32-1.21) per 100,000 children. CONCLUSIONS: Reported influenza-associated hospitalisations and fatalities demonstrate a high burden of influenza in the Austrian paediatric population corresponding with very low vaccination coverage.


Assuntos
Hospitalização/estatística & dados numéricos , Influenza Humana/mortalidade , Influenza Humana/terapia , Áustria/epidemiologia , Pré-Escolar , Bases de Dados Factuais , Feminino , Humanos , Lactente , Masculino , Estudos Retrospectivos , Estações do Ano
3.
Eur J Pediatr ; 175(6): 833-40, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26992931

RESUMO

UNLABELLED: The harmful effects of smoking during pregnancy are well known, but we lack prevalence data concerning this subject in Austria. The aim ofz the present study was to determine the prevalence and any changes in the prevalence of smoking during pregnancy in the last few years. The investigation was conducted at a perinatal center in Vienna, Austria. Further aims of the study were to evaluate maternal characteristics associated with smoking and demonstrate the harmful effects of smoking on neonatal outcome in this population. Once inquired, self-reported smoking during pregnancy, maternal age, and neonatal data from 2007 to 2012 were evaluated retrospectively. Of birth records, 11,142 were analyzed. From 2007 to 2012, the prevalence of smoking declined significantly from 19.1 to 15.6 %. The overall prevalence was 18.1 % and was highest (43.7 %) among young women (<20 years). The risk of small for gestational age (SGA) was significantly higher among newborns of smoking mothers. CONCLUSION: The prevalence of smoking among pregnant women has declined in Austria in the last few years but is still quite high. Prevention programs should focus on young women, who are at highest risk in this regard. WHAT IS KNOWN: • Smoking during pregnancy is known to exert harmful effects What is New: • Paucity of epidemiological data regarding this subject in Austria • Significant decline of self-reported smoking during pregnancy from 2007 to 2012 in Vienna.


Assuntos
Gestantes , Fumar/epidemiologia , Adulto , Distribuição por Idade , Áustria/epidemiologia , Feminino , Humanos , Recém-Nascido , Recém-Nascido Pequeno para a Idade Gestacional , Idade Materna , Gravidez , Complicações na Gravidez , Prevalência , Estudos Retrospectivos , Risco , Fatores de Risco , Autorrelato , Fumar/efeitos adversos , Centros de Atenção Terciária/estatística & dados numéricos , Adulto Jovem
4.
Wien Med Wochenschr ; 171(5-6): 142-143, 2021 04.
Artigo em Alemão | MEDLINE | ID: mdl-33754243
5.
Eur J Pediatr ; 174(12): 1639-47, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26109012

RESUMO

The human parechovirus (HPeV), mainly genotype 3, may cause severe illness in young infants and neonates, including sepsis-like illness and central nervous system (CNS) infection. We lack data concerning the impact and symptoms of HPeV infection in infants in Austria. The aim of the study is to evaluate the spectrum of symptoms and findings in infants with the parechovirus in Vienna and its environs. Patients younger than 3 months of age, with clinically suspected sepsis-like illness or CNS infection and a positive polymerase chain reaction (PCR) for HPeV, were included in the study. Medical records were analyzed retrospectively. Twenty patients were included in the study from 2009 to 2013. The most frequent manifestations were fever and neurological symptoms (89 and 80 %, respectively). Fifty percent of the infants had white blood cell counts out of range. The most notable aspect was cerebral hemorrhage in three neonates, which has not been reported earlier in association with HPeV infection. CONCLUSION: In Austria, HPeV is a relevant pathogen in sepsis-like disease in infants. The clinical presentation is similar to that described in other studies; cerebral hemorrhage is a new aspect. WHAT IS KNOWN: • Parechovirus infection can cause severe illness in infants. • Symptoms have been described to involve all organs; sepsis-like signs, fever, and irritability are most frequent. WHAT IS NEW: • Also in Austria, HPeV plays an important role in severe illnesses in infants. • Severe intracranial hemorrhage is described as a new finding.


Assuntos
Infecções do Sistema Nervoso Central/virologia , Hemorragias Intracranianas/virologia , Parechovirus/isolamento & purificação , Infecções por Picornaviridae/virologia , Áustria/epidemiologia , Infecções do Sistema Nervoso Central/diagnóstico , Infecções do Sistema Nervoso Central/epidemiologia , Feminino , Humanos , Lactente , Recém-Nascido , Hemorragias Intracranianas/diagnóstico , Hemorragias Intracranianas/epidemiologia , Masculino , Infecções por Picornaviridae/diagnóstico , Infecções por Picornaviridae/epidemiologia , Reação em Cadeia da Polimerase , RNA Viral/genética , Estudos Retrospectivos , Sepse
7.
Wien Med Wochenschr ; 169(13-14): 305-306, 2019 10.
Artigo em Alemão | MEDLINE | ID: mdl-31598886
8.
Pediatr Infect Dis J ; 43(5): 410-414, 2024 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-38266234

RESUMO

BACKGROUND: The aim of the study was to determine the burden of respiratory syncytial virus (RSV) and influenza disease during the COVID-19 pandemic at 2 Austrian urban pediatric centers between October 1, 2019 and April 30, 2022. METHODS: We performed a retrospective observational 2-center study on RSV- and influenza virus-associated hospitalizations in infants and children up to 18 years at the University Hospital of Graz and the Clinic Donaustadt of Vienna from October 1, 2019 to April 30, 2022. Hospitalization had to be associated with the infectious disease, proven by polymerase chain reaction, including presence of respiratory symptoms. Demographic data including underlying diseases and treatment strategies were compared between centers and diseases, respectively. RESULTS: There were 826 cases in Graz and 379 in Vienna with significant more RSV cases in Graz and more influenza cases in Vienna (RSV: 76% vs. 59%, influenza: 24% vs. 41%; both P < 0.001). One death occurred in Graz due to RSV and another due to influenza in Vienna. Seasonality only slightly differed between centers and severity of diseases was not aggravated when measured by pediatric intensive care unit admission rates, need for supplemental oxygen and respiratory support between first and last seasons. Treatment regimen differed regarding higher use of antibiotics and rates of intravenous fluids in Vienna compared to higher rates of bronchodilators, corticosteroids and nose drops in Graz. CONCLUSIONS: We observed higher numbers of hospitalizations due to both viruses after the lockdown but not increased severity of the diseases; and mortality remained extremely low. Preventive measures should be implemented with high priority especially focused on infants with underlying diseases.


Assuntos
COVID-19 , Influenza Humana , Infecções por Vírus Respiratório Sincicial , Vírus Sincicial Respiratório Humano , Lactente , Criança , Humanos , Influenza Humana/epidemiologia , Influenza Humana/diagnóstico , Infecções por Vírus Respiratório Sincicial/prevenção & controle , Estudos Retrospectivos , Pandemias , COVID-19/epidemiologia , Controle de Doenças Transmissíveis , Hospitalização
9.
Wien Med Wochenschr ; 162(7-8): 158-63, 2012 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-22614541

RESUMO

BACKGROUND: Malaria is the most frequent tropical disease and the most important parasitic infectious disease in the world. Due to high mobility by travelling and migration also in Central Europe malaria has to be considered also in children and youths. METHODS: We report four cases of malaria being diagnosed and treated at the department of paediatrics, Vienna Danube Hospital, a municipal centre. RESULTS: In all cases the latency time or incubation period respectively was long with up to one year which made the diagnosis of malaria unlikely at first glance. CONCLUSIONS: Taking into account the long latency or incubation period and often fragmentary report of medical history malaria has to be considered in all children after a stay in a country at risk for malaria even if this stay dates back a long time in order to diagnose and treat this disease quickly.


Assuntos
Hospitais Municipais , Período de Incubação de Doenças Infecciosas , Malária/diagnóstico , Viagem , Adolescente , Antimaláricos/uso terapêutico , Áustria , Criança , Diagnóstico Diferencial , Emigrantes e Imigrantes , Feminino , Fidelidade a Diretrizes , Interações Hospedeiro-Parasita , Humanos , Índia/etnologia , Malária/tratamento farmacológico , Malária/parasitologia , Masculino , Nigéria/etnologia , Plasmodium/classificação , Recidiva , Uganda/etnologia
10.
Wien Med Wochenschr ; 162(7-8): 164-7, 2012 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-22614542

RESUMO

As immunization coverage of varicella vaccination is low, the disease is still very frequent in Austria. Albeit the prognosis in general is good, the incidence of varicella-related hospitalization is about 6 per 100,000 in all children between 0-15 years of age, affecting mainly previously healthy children. Especially young children under the age of 5 are at risk with highest rates among children younger than one year. The most common complications are secondary bacterial infections, neurological and respiratory complications. Two cases of life threatening secondary bacterial infection are presented. One child suffered from a Toxic Shock Syndrome caused by group A streptococcus along with large necrotizing skin lesions. The second child nearly lost her left eye due to a deep orbital abscess. Both children survived without severe sequelae but had to undergo several procedures of plastic surgery. Implementation of the varicella vaccination program in the USA has shown a near elimination of deaths due to severe varicella complications. The initiation of the varicella vaccination program for children until the age of 2 in Austria should be considered to prevent complications and deaths caused by varicella.


Assuntos
Abscesso/diagnóstico , Varicela/diagnóstico , Doenças Orbitárias/diagnóstico , Choque Séptico/diagnóstico , Dermatopatias Bacterianas/diagnóstico , Infecções Estreptocócicas/diagnóstico , Streptococcus pyogenes , Superinfecção/diagnóstico , Varicela/prevenção & controle , Varicela/terapia , Vacina contra Varicela/administração & dosagem , Pré-Escolar , Terapia Combinada , Feminino , Humanos , Lactente , Unidades de Terapia Intensiva Pediátrica , Imageamento por Ressonância Magnética , Necrose , Órbita/patologia , Doenças Orbitárias/terapia , Choque Séptico/terapia , Pele/patologia , Dermatopatias Bacterianas/terapia , Infecções Estreptocócicas/terapia , Superinfecção/terapia
11.
Front Pediatr ; 10: 816221, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35299673

RESUMO

Objective: Very low birthweight (VLBW) infants have an increased risk of mortality and frequently suffer from complications, which affects parental occupational balance. Occupational balance is the satisfaction with one's meaningful activities, which include everyday activities that people need to, want to, and are expected to do. In contrast to work-life balance, the construct of occupational balance addresses different activities equally and it applies to all persons, regardless of whether they are working or not. Parental occupational balance might be related to parents' and VLBW infants' health. Therefore, the objective of this study was to investigate associations between parental occupational balance, subjective health, and clinical characteristics of VLBW infants. Methods: A cross-sectional multicenter study was conducted in six Austrian neonatal intensive care units. Occupational balance and subjective health of parents of VLBW infants were assessed with six self-reported questionnaires. The following clinical characteristics of VLBW infants were extracted from medical records: gestational age, birthweight, Apgar scores, Clinical Risk for Babies II Score, and complications of prematurity. Spearman's rank coefficients were calculated. Results: In total, 270 parents, 168 (62%) female and their VLBW infants, 120 (44%) female, were included in this study. Parents' mean age was 33.7 (±6.0) years, mean gestational age of VLBW infants was 27 + 3 (±2) weeks. Associations between parental occupational balance, subjective health, and clinical characteristics of VLBW infants were identified (r s = 0.13 - 0.56; p ≤ 0.05), such as the correlation between occupational areas (r s = 0.22, p ≤ 0.01), occupational characteristics (r s = 0.17, p = 0.01), and occupational resilience (r s = 0.18, p ≤ 0.01) with bronchopulmonary dysplasia of VLBW infants. Conclusion: Occupational balance is associated with parents' and VLBW infants' health. Interventions to strengthen parental occupational balance might increase parental health and thereby also improve health and developmental outcomes of their VLBW infants.

12.
Wien Med Wochenschr ; 161(7-8): 180-3, 2011 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-20963506

RESUMO

BACKGROUND: Epidemiology and morbidity of mycoplasma-associated pneumonia in youths and children in Vienna are not known. The first objective was to elucidate the incidence and the second was to evaluate a standard antibiotic regimen with addition of a macrolid in children over 5 years. METHODS: Hospitalized patients were evaluated prospectively during 3 winter seasons. In a clinical routine setting microbiologic tests were performed, nasal secretions were tested for viruses, Chlamydia pneumoniae and Mycoplasma pneumoniae, and clinical parameters were documented. RESULTS: Mycoplasma pneumoniae was identified in 12 patients out of 279 (4.3%). All were 5 years and older. The mean number of days in hospital was 4.6, the number of days with fever > 38.5 degrees was 1.2, the maximal value of C-reactive protein was 48 mg/L, no complications occurred, and all children recovered completely. CONCLUSION: Mycoplasma pneumoniae was identified in 4.3% of children and youths. The antibiotic regimen is appropriate as initial therapy.


Assuntos
Infecções Comunitárias Adquiridas/epidemiologia , Hospitalização/estatística & dados numéricos , Pneumonia por Mycoplasma/epidemiologia , Administração Oral , Adolescente , Antibacterianos/administração & dosagem , Áustria , Proteína C-Reativa/metabolismo , Cefuroxima/administração & dosagem , Criança , Claritromicina/administração & dosagem , Infecções Comunitárias Adquiridas/tratamento farmacológico , Estudos Transversais , Quimioterapia Combinada , Uso de Medicamentos/estatística & dados numéricos , Feminino , Hospitais Comunitários , Humanos , Incidência , Infusões Intravenosas , Tempo de Internação/estatística & dados numéricos , Macrolídeos/uso terapêutico , Masculino , Pneumonia por Mycoplasma/tratamento farmacológico , Estudos Prospectivos
13.
Wien Med Wochenschr ; 161(7-8): 204-8, 2011 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-21253816

RESUMO

Painful, aseptic osteitis remains the major problem in the treatment of patients with SAPHO syndrome. We present a child suffering of both sacroiliitis and acne conglobata in the context of SAPHO syndrome. While acne lesions responded well to systemic isotretinoin, sacroiliitis associated pain could be controlled neither by NSAR nor by intralesional or systemic steroid injection. Worse pain limited substantially patient's mobility. This changed immediately after starting etanercept. Within a few days, pain resolved and the patient regained his mobility. This favourable response lasted for 8 months when we tried to stop etanercept under protection with the DMARD sulfazalazin. Unfortunately, within a few days, pain and immobility re-occurred requiring reinstitution of etanercept. This case demonstrates that, similar to other reports, TNF blockade is able to induce prompt and long-lasting response of SAPHO syndrome associated osteoarthritis to TNF blockade.


Assuntos
Síndrome de Hiperostose Adquirida/tratamento farmacológico , Antirreumáticos/uso terapêutico , Imunoglobulina G/uso terapêutico , Receptores do Fator de Necrose Tumoral/uso terapêutico , Sacroileíte/tratamento farmacológico , Acne Vulgar/diagnóstico , Acne Vulgar/tratamento farmacológico , Síndrome de Hiperostose Adquirida/diagnóstico , Adolescente , Antirreumáticos/efeitos adversos , Áustria , Etanercepte , Humanos , Imunoglobulina G/efeitos adversos , Imageamento por Ressonância Magnética , Masculino , Limitação da Mobilidade , Medição da Dor/efeitos dos fármacos , Sacroileíte/diagnóstico , Espondilite Anquilosante/diagnóstico , Espondilite Anquilosante/tratamento farmacológico , Turquia/etnologia
14.
Front Pediatr ; 9: 656768, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34178882

RESUMO

MIS-C is a novel clinical syndrome in children and adolescents, was first encountered in the spring of 2020 as a post COVID-19 multisystem inflammatory syndrome. The highest number of SARS-CoV-2 infections in Austria were registered in November 2020. In December 2020, eight patients with MIS-C were hospitalized at the pediatric department of Klinik Donaustadt, a large municipal hospital in Vienna. Six of the patients needed pediatric intensive care. As we lack any international consensus on the diagnosis and treatment of this severe complication, we used a multidisciplinary approach. The purpose was to establish an internal standard for maximizing the efficacy and safety of treatment, and standardizing the clinical management of this disease.

15.
PLoS One ; 16(11): e0259648, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34780508

RESUMO

BACKGROUND: Parents' meaningful activities (occupations) and occupational balance are relevant to neonatal care. Valid and reliable self-reported measurement instruments are needed to assess parents' occupational balance and to evaluate occupational balance interventions in neonatal care. The aims of this study were to develop a self-reported questionnaire on occupational balance in informal caregivers (OBI-Care) and to examine its measurement properties including construct validity and internal consistency. METHODS AND FINDINGS: A mixed method multicenter study design was employed. Items of the OBI-Care were created with parents of preterm infants based on qualitative research methods. Measurement properties were analyzed with quantitative data of parents of preterm infants. Construct validity was assessed by determining dimensionality, overall and item fit to a Rasch model, differential item functioning and threshold ordering. Internal consistency was examined by determining inter-item and item-total correlations, Cronbach's alpha and Rasch's person separation index. Fourteen parents participated in item creation. Measurement properties were explored in data of 304 parents. Twenty-two items, summarized in three subscales were compiled to the OBI-Care. Items showed an overall fit and except one item, an item fit to the Rasch model. There was no evidence of differential item functioning and all items displayed ordered thresholds. Each subscale had good values of person separation indices and Cronbach's alpha. CONCLUSIONS: The OBI-Care demonstrates construct validity and internal consistency and is thus a suitable measurement instrument to assess occupational balance of parents of preterm infants in neonatal care. OBI-Care is generic and can be applied in various health care settings.


Assuntos
Inquéritos e Questionários , Adulto , Cuidadores/estatística & dados numéricos , Feminino , Humanos , Recém-Nascido Prematuro , Masculino , Pessoa de Meia-Idade , Projetos de Pesquisa , Autorrelato
16.
Clin Chem Lab Med ; 47(9): 1141-5, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19634984

RESUMO

BACKGROUND: The potential for faster detection of human herpes viruses using PCR compared to other methods is undisputed. However, because of fear of contamination, the clinical implication of nucleic amplification methods in routine laboratories is not widespread. Herpes viruses cause a wide spectrum of diseases and can cause morbidity and mortality in immune-compromised patients. Using real-time PCR, most of the problems associated with PCR (contamination, cumbersome detection, and rather expensive tests) are solved, and a rapid, economical, and--most importantly--closed system is at hand. METHODS: We evaluated work procedures in our laboratory that enable the routine diagnosis of viral infections with high accuracy and rapid turn-around time. In parallel, inherent problems usually associated with PCR testing, especially cross-contamination could be suppressed to a minimum. The start of the work flow process begins with an automated nucleic acid extraction procedure that yields high quality DNA. A common--internally and externally controlled--PCR program for all six viruses allows rapid sample turn around. RESULTS: In all, 7500 analyses for human herpes virus infection were performed in the last 5 years. Results for various different specimens were produced within 24 h. Contamination occurred rarely and could be ameliorated easily. The use of internal controls identified rare PCR-inhibited samples. The detection limits for our assays are markedly below the clinically relevant range. CONCLUSIONS: Our workflow allowed rapid, cost-efficient, and labor saving routine diagnostic detection of viral infections.


Assuntos
Infecções por Herpesviridae/diagnóstico , Herpesviridae/isolamento & purificação , Reação em Cadeia da Polimerase/métodos , Técnicas de Laboratório Clínico , Herpesviridae/genética , Humanos
19.
Wien Klin Wochenschr ; 118(11-12): 362-4, 2006 Jun.
Artigo em Alemão | MEDLINE | ID: mdl-16855927

RESUMO

Recent publications suggest that long-acting beta-2 agonists (LABAs) increase the risk for death in asthma. The American Food and Drug Administration (FDA) published a relevant alert in 2005. In the currently valid Austrian consensus guidelines for drug therapy of bronchial asthma in children and adolescents, LABAs are only recommended as add-on therapy in those patients whose asthma is not sufficiently controlled by inhaled corticosteroids (ICS) alone. LABAs have no established role in earlier steps of the therapeutic algorithm; consequently, the prescription of ICS-LABA combinations for initial treatment of paediatric asthma is not supported by these consensus treatment guidelines.


Assuntos
Agonistas Adrenérgicos beta/efeitos adversos , Agonistas Adrenérgicos beta/uso terapêutico , Antiasmáticos/efeitos adversos , Antiasmáticos/uso terapêutico , Asma/tratamento farmacológico , Asma/mortalidade , Guias de Prática Clínica como Assunto , Áustria , Preparações de Ação Retardada , Medição de Risco/métodos , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA